Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by mediascan59on Aug 10, 2010 9:51am
382 Views
Post# 17336891

RE: RE: RE: RE: Any Comments?

RE: RE: RE: RE: Any Comments?I think you need to stand outside the box here.
If you do not own sss.v and read this piece of news it does not make you want to invest in this play.
And if there was any indication that a phase 111 would be happening soon, these directors would not leave the company at this time.
This may not be the final nail in the coffin, but it is sure not looking good.
Two months ago, I would have recommended this play to everyone, today unfortunately not.
I would say, take what you can, and if things turn out later, then lots of time to jump back in.
Take care all, sorry to hear this latest bit of news.

Mediascan
Bullboard Posts